Key Insights

Highlights

Success Rate

50% trial completion

Treatment Research

8 treatments under study, led by Mesenchymal Stem Cells

Research Leaders

11 sponsors active, led by University Hospital Tuebingen

Related Conditions

Often studied with 9 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

11.1%

1 terminated out of 9 trials

Success Rate

50.0%

-36.6% vs benchmark

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results50% success

Data Visualizations

Phase Distribution

4Total
Not Applicable (1)
Phase 1 (1)
Phase 2 (1)
Phase 4 (1)

Trial Status

Unknown6
Completed1
Terminated1
Recruiting1

Trial Success Rate

50.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (9)

Research Network

Common Treatments

  • Mesenchymal Stem Cells1
  • Mycophenolate Mofetil1
  • Pediatric Liver Transplantation1
  • Weaning From Mechanical Ventilation1
  • Tacrolimus1

Active Sponsors

  • University Hospital Tuebingen1
  • Queen Silvia Children's Hospital, Gothenburg, Sweden1
  • Assiut University1
  • Institute of Liver and Biliary Sciences, India1
  • Roche1

Top Investigators

Related Conditions

  • Socioemotional Delay1
  • Postoperative Acute Kidney Injury1
  • Intestinal Failureassociated Liver Disease1
  • Developmental Delay1
  • Mafld1

Activity Timeline